2022年日本一家地区医院孕妇中8种病毒和百日咳的血清阳性率:与以往研究的比较

IF 1.1 4区 医学 Q4 INFECTIOUS DISEASES
Koji Takemoto, Naoko Nishimura, Haruna Kuriyama, Yotaro Kondo, Masanori Sugiura, Mai Umehara, Takuya Akano, Mami Watarai, Kanayo Ochiai, Haruka Mimatsu, Kensei Gotoh, Takao Ozaki
{"title":"2022年日本一家地区医院孕妇中8种病毒和百日咳的血清阳性率:与以往研究的比较","authors":"Koji Takemoto, Naoko Nishimura, Haruna Kuriyama, Yotaro Kondo, Masanori Sugiura, Mai Umehara, Takuya Akano, Mami Watarai, Kanayo Ochiai, Haruka Mimatsu, Kensei Gotoh, Takao Ozaki","doi":"10.7883/yoken.JJID.2024.307","DOIUrl":null,"url":null,"abstract":"<p><p>This study evaluated the prevalence of antibodies against eight viruses and pertussis in the serum collected from 191 pregnant women in 2022. Serum IgG antibodies against the following viruses and pertussis toxin (PT) were measured: measles virus (MV), rubella virus (RV), mumps virus (MuV), varicella-zoster virus (VZV), herpes simplex virus (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), and human parvovirus B19 (PVB19). Infection history and immunization status were simultaneously obtained using a survey questionnaire for vaccine-preventable diseases of measles, rubella, mumps, varicella, and pertussis. Our results were compared with those of our previous studies using umbilical cord blood samples in 2001-2002 and 2013 for eight viruses and a 2016-2018 study for pertussis. Seroprevalence data in 2022 were 88.5% for MV; 86.4% for RV; 46.1% for MuV; 91.1% for VZV; 47.6% for HSV; 61.3% for CMV; 93.7% for EBV; 69.6% for PVB19 and 63.4% for PT. The seroprevalence of all diseases, except for PVB19 and pertussis, continued to decline over time. The mean IgG antibody titers were significantly lower and the vaccination coverage rates were significantly higher in four vaccine-preventable viral diseases than previous results. Thus, trends in seroprevalence status for these pathogens should be monitored in pregnant women.</p>","PeriodicalId":14608,"journal":{"name":"Japanese journal of infectious diseases","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Seroprevalence of eight viruses and pertussis in pregnant women at a regional hospital in Japan in 2022: Comparison with previous studies.\",\"authors\":\"Koji Takemoto, Naoko Nishimura, Haruna Kuriyama, Yotaro Kondo, Masanori Sugiura, Mai Umehara, Takuya Akano, Mami Watarai, Kanayo Ochiai, Haruka Mimatsu, Kensei Gotoh, Takao Ozaki\",\"doi\":\"10.7883/yoken.JJID.2024.307\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This study evaluated the prevalence of antibodies against eight viruses and pertussis in the serum collected from 191 pregnant women in 2022. Serum IgG antibodies against the following viruses and pertussis toxin (PT) were measured: measles virus (MV), rubella virus (RV), mumps virus (MuV), varicella-zoster virus (VZV), herpes simplex virus (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), and human parvovirus B19 (PVB19). Infection history and immunization status were simultaneously obtained using a survey questionnaire for vaccine-preventable diseases of measles, rubella, mumps, varicella, and pertussis. Our results were compared with those of our previous studies using umbilical cord blood samples in 2001-2002 and 2013 for eight viruses and a 2016-2018 study for pertussis. Seroprevalence data in 2022 were 88.5% for MV; 86.4% for RV; 46.1% for MuV; 91.1% for VZV; 47.6% for HSV; 61.3% for CMV; 93.7% for EBV; 69.6% for PVB19 and 63.4% for PT. The seroprevalence of all diseases, except for PVB19 and pertussis, continued to decline over time. The mean IgG antibody titers were significantly lower and the vaccination coverage rates were significantly higher in four vaccine-preventable viral diseases than previous results. Thus, trends in seroprevalence status for these pathogens should be monitored in pregnant women.</p>\",\"PeriodicalId\":14608,\"journal\":{\"name\":\"Japanese journal of infectious diseases\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2025-03-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese journal of infectious diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7883/yoken.JJID.2024.307\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese journal of infectious diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7883/yoken.JJID.2024.307","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

本研究评估了2022年从191名孕妇收集的血清中抗8种病毒和百日咳抗体的患病率。测定血清抗麻疹病毒(MV)、风疹病毒(RV)、腮腺炎病毒(MuV)、水痘-带状疱疹病毒(VZV)、单纯疱疹病毒(HSV)、巨细胞病毒(CMV)、eb病毒(EBV)、人细小病毒B19 (PVB19)及百日咳毒素(PT) IgG抗体。通过麻疹、风疹、腮腺炎、水痘和百日咳等疫苗可预防疾病的调查问卷,同时获得感染史和免疫状况。我们的研究结果与我们之前在2001-2002年和2013年使用脐带血样本对八种病毒进行的研究以及2016-2018年对百日咳的研究进行了比较。2022年MV血清阳性率为88.5%;RV占86.4%;MuV占46.1%;VZV为91.1%;HSV占47.6%;CMV为61.3%;EBV占93.7%;PVB19阳性率为69.6%,PT阳性率为63.4%。除PVB19和百日咳外,所有疾病的血清阳性率随时间持续下降。4种疫苗可预防病毒性疾病的平均IgG抗体滴度显著低于既往结果,疫苗接种率显著高于既往结果。因此,应监测孕妇血清中这些病原体的流行趋势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Seroprevalence of eight viruses and pertussis in pregnant women at a regional hospital in Japan in 2022: Comparison with previous studies.

This study evaluated the prevalence of antibodies against eight viruses and pertussis in the serum collected from 191 pregnant women in 2022. Serum IgG antibodies against the following viruses and pertussis toxin (PT) were measured: measles virus (MV), rubella virus (RV), mumps virus (MuV), varicella-zoster virus (VZV), herpes simplex virus (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), and human parvovirus B19 (PVB19). Infection history and immunization status were simultaneously obtained using a survey questionnaire for vaccine-preventable diseases of measles, rubella, mumps, varicella, and pertussis. Our results were compared with those of our previous studies using umbilical cord blood samples in 2001-2002 and 2013 for eight viruses and a 2016-2018 study for pertussis. Seroprevalence data in 2022 were 88.5% for MV; 86.4% for RV; 46.1% for MuV; 91.1% for VZV; 47.6% for HSV; 61.3% for CMV; 93.7% for EBV; 69.6% for PVB19 and 63.4% for PT. The seroprevalence of all diseases, except for PVB19 and pertussis, continued to decline over time. The mean IgG antibody titers were significantly lower and the vaccination coverage rates were significantly higher in four vaccine-preventable viral diseases than previous results. Thus, trends in seroprevalence status for these pathogens should be monitored in pregnant women.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.50
自引率
4.50%
发文量
172
审稿时长
2 months
期刊介绍: Japanese Journal of Infectious Diseases (JJID), an official bimonthly publication of National Institute of Infectious Diseases, Japan, publishes papers dealing with basic research on infectious diseases relevant to humans in the fields of bacteriology, virology, mycology, parasitology, medical entomology, vaccinology, and toxinology. Pathology, immunology, biochemistry, and blood safety related to microbial pathogens are among the fields covered. Sections include: original papers, short communications, epidemiological reports, methods, laboratory and epidemiology communications, letters to the editor, and reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信